• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute , 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More Standards PDF

CSA B108.1:23

CSA B108.1:23

$55.00 $110.00

CGA G-11.1

CGA G-11.1

$26.00 $52.00

CSA B64.10:23/CSA B64.10.1:23
CGA P-41

CGA P-41

$24.00 $49.00